A pilot study at Duke University Medical Center found that bupropion SR combined with a 1,600-calorie diet resulted in significant weight loss among non-depressed women. The study showed a 6.21% weight loss in the treatment group compared to 1.56% in the placebo group.
A combination of nefazodone and psychotherapy is more effective than either medication or therapy alone in treating chronic depression, with an 85% response rate. The study also found significant improvement in insomnia and early symptom reduction.
Recent feminism has brought deeper changes to specific sciences like medicine, anthropology, archaeology, biology, physics, and mathematics. Medicine has seen increased funding for women's health, such as osteoporosis and heart disease research.
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
A new color-coded chromosome mapping system devised by Julie R. Korenberg enables quick localization of known matching genes in humans using mouse DNA, greatly speeding up research into Down Syndrome and other human illnesses. The system has profound implications for the study of human diseases and the development of effective treatments.
SourceCedars-Sinai Medical Center·JournalGenome Research·DateMay 18, 1999
Children between 2-18 years old had the best success with a five-year survival rate of 68%, followed by adults with Crohn's disease. Intestinal transplantation improves quality of life, reducing reliance on intravenous nutrition and hospitalizations.
SourceUniversity of Pittsburgh Medical Center·DateMay 18, 1999
The study found that the costs of treating patients in clinical trials were modestly higher than for those who opted for standard treatment, with an average total cost of $46,424. The authors recommend payment for patients' treatment in National Cancer Institute-approved clinical trials to improve access and patient outcomes.
SourceMayo Clinic·JournalJNCI Journal of the National Cancer Institute·DateMay 18, 1999
After 20 years, NASA's Far Ultraviolet Spectroscopic Explorer (FUSE) satellite is nearing its scheduled June 23 launch. The project faced numerous setbacks, including the Challenger rocket explosion and budget cuts, but ultimately, Johns Hopkins University took over management and implemented cost-saving measures.
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
Researchers use ultraviolet lamps to create thin polymer films with precise patterns, reducing convection issues that affect film uniformity. These films have the potential to replace electronic circuits in all-optical computer systems, increasing efficiency and compactness.
SourceNASA/Marshall Space Flight Center--Space Sciences Laboratory·DateMay 18, 1999
A USCF study reveals that an herbal therapy, PC-SPES, significantly reduces prostate-specific antigen (PSA) levels by more than 50% in men with advanced prostate cancer. The compound, containing eight Chinese herbs including saw palmetto, showed promising results in both hormone-naïve and hormone-resistant patients.
SourceUniversity of California - San Francisco·DateMay 18, 1999
Scientists have developed sheets of single-walled nanotubes that generate higher stresses than natural muscle and higher strains than high-modulus ferroelectrics. The carbon nanotube actuators work in aqueous environments, including salt water, and require small voltages to produce large length changes.
SourceMax-Planck-Gesellschaft·JournalScience·DateMay 18, 1999
The American Psychiatric Association is establishing the first comprehensive guidelines for treating persons with HIV infection and AIDS. The new guidelines will focus on access to care, treatment adherence, education, prevention, and direct mental health services.
SourceEmory University Health Sciences Center·DateMay 18, 1999
Abgenix's Phase II trial shows 56% of patients survived at least 100 days with high-dose ABX-CBL, outperforming low-dose cohort. The company plans a pivotal Phase III clinical trial for ABX-CBL after FDA approval.
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.